Abingdon Health, a global developer, manufacturer and regulatory services provider for diagnostics and med-tech with a specialty in lateral flow technology, announces a 40% increase in total FY 2025 revenues to £8.6m from £6.1m. Strong H2 25 performance was driven by a range of CDMO contract wins, a full period contribution from acquired regulatory businesses and an improving industry outlook. Abingdon operates from a stronger base and with broader expertise investing in US expansion, UK capabil ....
